175 related articles for article (PubMed ID: 25325293)
1. Stability of avoidance behaviour following repeated intermittent treatment with clozapine, olanzapine or D,L-govadine.
Ashby DM; Lapish CC; Phillips AG
Behav Pharmacol; 2015 Feb; 26(1-2):133-8. PubMed ID: 25325293
[TBL] [Abstract][Full Text] [Related]
2. Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning.
Li M; Sun T; Zhang C; Hu G
Psychopharmacology (Berl); 2010 Sep; 212(1):45-57. PubMed ID: 20623111
[TBL] [Abstract][Full Text] [Related]
3. A preclinical assessment of d.l-govadine as a potential antipsychotic and cognitive enhancer.
Lapish CC; Belardetti F; Ashby DM; Ahn S; Butts KA; So K; Macrae CM; Hynd JJ; Miller JJ; Phillips AG
Int J Neuropsychopharmacol; 2012 Nov; 15(10):1441-55. PubMed ID: 22071247
[TBL] [Abstract][Full Text] [Related]
4. Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity.
Qin R; Chen Y; Li M
Neuropharmacology; 2013 Dec; 75():356-64. PubMed ID: 23954676
[TBL] [Abstract][Full Text] [Related]
5. Olanzapine sensitization and clozapine tolerance: from adolescence to adulthood in the conditioned avoidance response model.
Qiao J; Li H; Li M
Neuropsychopharmacology; 2013 Feb; 38(3):513-24. PubMed ID: 23132270
[TBL] [Abstract][Full Text] [Related]
6. Long-term impacts of adolescent risperidone treatment on behavioral responsiveness to olanzapine and clozapine in adulthood.
Qiao J; Zhang Q; Li M
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():177-85. PubMed ID: 24140929
[TBL] [Abstract][Full Text] [Related]
7. Positive modulation of glutamatergic receptors potentiates the suppressive effects of antipsychotics on conditioned avoidance responding in rats.
Olsen CK; Kreilgaard M; Didriksen M
Pharmacol Biochem Behav; 2006 Jun; 84(2):259-65. PubMed ID: 16782180
[TBL] [Abstract][Full Text] [Related]
8. Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.
Chou S; Davis C; Jones S; Li M
Pharmacol Biochem Behav; 2015 Jan; 128():78-88. PubMed ID: 25433325
[TBL] [Abstract][Full Text] [Related]
9. Avoidance disruptive effect of clozapine and olanzapine is potentiated by increasing the test trials: further test of the motivational salience hypothesis.
Feng M; Sui N; Li M
Pharmacol Biochem Behav; 2013 Jan; 103(3):467-73. PubMed ID: 23026062
[TBL] [Abstract][Full Text] [Related]
10. Effects of D- and L-govadine on the disruption of touchscreen object-location paired associates learning in rats by acute MK-801 treatment.
Lins BR; Phillips AG; Howland JG
Psychopharmacology (Berl); 2015 Dec; 232(23):4371-82. PubMed ID: 26359226
[TBL] [Abstract][Full Text] [Related]
11. Dissociable effects of the
Lins BR; Marks WN; Phillips AG; Howland JG
Psychopharmacology (Berl); 2017 Apr; 234(7):1079-1091. PubMed ID: 28180960
[TBL] [Abstract][Full Text] [Related]
12. Selective effects of D- and L-govadine in preclinical tests of positive, negative, and cognitive symptoms of schizophrenia.
Lapish CC; Ahn KC; Chambers RA; Ashby DM; Ahn S; Phillips AG
Neuropsychopharmacology; 2014 Jun; 39(7):1754-62. PubMed ID: 24476944
[TBL] [Abstract][Full Text] [Related]
13. Time-dependent sensitization of antipsychotic effect in adolescent male and female rats.
Ding X; Li X; Shu Q; Wu R; Hu G; Li M
Behav Brain Res; 2017 Jun; 328():186-194. PubMed ID: 28412306
[TBL] [Abstract][Full Text] [Related]
14. The effects of d-govadine on conditioned place preference with d-amphetamine or food reward.
Nesbit MO; Dias C; Phillips AG
Behav Brain Res; 2017 Mar; 321():223-231. PubMed ID: 28062254
[TBL] [Abstract][Full Text] [Related]
15. Continuous oral olanzapine or clozapine treatment initiated in adolescence has differential short- and long-term impacts on antipsychotic sensitivity than those initiated in adulthood.
Wu R; Chou S; Li M
Eur J Pharmacol; 2024 Jun; 972():176567. PubMed ID: 38582275
[TBL] [Abstract][Full Text] [Related]
16. Sodium nitroprusside enhances the antipsychotic-like effect of olanzapine but not clozapine in the conditioned avoidance response test in rats.
Titulaer J; Radhe O; Mazrina J; Ström A; Svensson TH; Konradsson-Geuken Å
Eur Neuropsychopharmacol; 2022 Jul; 60():48-54. PubMed ID: 35635996
[TBL] [Abstract][Full Text] [Related]
17. A drug-drug conditioning paradigm reveals multiple antipsychotic-nicotine interactions.
Feng M; Sparkman NL; Sui N; Li M
J Psychopharmacol; 2017 Apr; 31(4):474-486. PubMed ID: 28347260
[TBL] [Abstract][Full Text] [Related]
18. The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063.
Assié MB; Carilla-Durand E; Bardin L; Maraval M; Aliaga M; Malfètes N; Barbara M; Newman-Tancredi A
Eur J Pharmacol; 2008 Sep; 592(1-3):160-6. PubMed ID: 18640111
[TBL] [Abstract][Full Text] [Related]
19. Using pharmacokinetic-pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics.
Olsen CK; Brennum LT; Kreilgaard M
Eur J Pharmacol; 2008 Apr; 584(2-3):318-27. PubMed ID: 18325493
[TBL] [Abstract][Full Text] [Related]
20. Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle.
Ballmaier M; Zoli M; Mazzoncini R; Gennarelli M; Spano F
Psychopharmacology (Berl); 2001 Dec; 159(1):105-10. PubMed ID: 11797077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
